A Comparative Analysis of the Safety Profile of Direct Oral Anticoagulants Using the FDA Adverse Event Reporting System

Documenti analoghi

• Direct oral anticoagulants in gastrointestinal malignancies: is the convenience worth the risk?
  di: Thapa, Namisha, et al.
  Pubblicazione: (2019)
• Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions
  di: Monaco, Luca, et al.
  Pubblicazione: (2017)
• MedWatch: The FDA Safety Information and Adverse Event Reporting Program
  di: Craigle, Valeri
  Pubblicazione: (2007)
• Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
  di: Shimada, Kazuyo, et al.
  Pubblicazione: (2019)
• Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system.
  di: Akiho Fukuda, et al.
  Pubblicazione: (2017-01-01)